Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Microscopy, Acoustic
Bodenhausen, Natacha
Cysticercosis
The pharmacogenetics research network: from SNP discovery to clinical drug response.
A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk.
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk.
A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk. Breast Cancer Res Treat. 2008 Oct; 111(3):481-7.
View in:
PubMed
subject areas
Aromatase
Breast Neoplasms
Case-Control Studies
Female
Gene Frequency
Genetic Predisposition to Disease
Haplotypes
Humans
Odds Ratio
Polymorphism, Single Nucleotide
Premenopause
Risk Assessment
Risk Factors
authors with profiles
Habibul Ahsan
Muhammad G. Kibriya